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Abstract
Background:  The follicle-stimulating hormone receptor (FSH-R) is a seven transmembrane
spanning receptor (7TMR) which plays a crucial role in male and female reproduction. Upon FSH
stimulation, the FSH-R activates the extracellular signal-regulated kinases (ERK). However, the
mechanisms whereby the agonist-stimulated FSH-R activates ERK are poorly understood. In order
to activate ERK, some 7 TMRs require beta-arrestin-and dynamin-dependent internalization to
occur, whereas some others do not. In the present study, we examined the ability of the FSH-
activated FSH-R to induce ERK phosphorylation, in conditions where its beta-arrestin- and
dynamin-mediated internalization was impaired.
Methods: Human embryonic kidney (HEK) 293 cells were transiently transfected with the rat
FSH-R. Internalization of the FSH-R was manipulated by co-expression of either a beta-arrestin
(319–418) dominant negative peptide, either an inactive dynamin K44A mutant or of wild-type
beta-arrestin 1 or 2. The outcomes on the FSH-R internalization were assayed by measuring 125I-
FSH binding at the cell surface when compared to internalized 125I-FSH binding. The resulting ERK
phosphorylation level was visualized by Western blot analysis.
Results: In HEK 293 cells, FSH stimulated ERK phosphorylation in a dose-dependent manner. Co-
transfection of the beta- arrestin (319–418) construct, or of the dynamin K44A mutant reduced
FSH-R internalization in response to FSH, without affecting ERK phosphorylation. Likewise,
overexpression of wild-type beta-arrestin 1 or 2 significantly increased the FSH-R internalization
level in response to FSH, without altering FSH-induced ERK phosphorylation.
Conclusion: From these results, we conclude that the FSH-R does not require beta-arrestin- nor
dynamin-mediated internalization to initiate ERK phosphorylation in response to FSH.
Published: 20 June 2006
Reproductive Biology and Endocrinology 2006, 4:33 doi:10.1186/1477-7827-4-33
Received: 11 April 2006
Accepted: 20 June 2006
This article is available from: http://www.rbej.com/content/4/1/33
© 2006 Piketty et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Reproductive Biology and Endocrinology 2006, 4:33 http://www.rbej.com/content/4/1/33
Page 2 of 11
(page number not for citation purposes)
Background
ERK mitogen-activated protein (MAP) kinases are com-
monly activated by 7TMRs, which leads to a wide array of
cellular processes including cell proliferation and cell dif-
ferentiation. In the last decade, a tremendous amount of
works have been dedicated to elucidate the cell signaling
mechanisms whereby 7TMRs activate ERK. To achieve
ERK activation, some 7TMRs, such as the lutropin receptor
[1], rely solely on G protein activation and to second mes-
senger production. Besides, several reports support the
view that MAP kinase activation requires receptor inter-
nalization, mediated by β-arrestins [2]. Originally, β-
arrestins have been viewed as responsible for receptor
desensitization, by uncoupling an agonist-activated recep-
tor from its effector G proteins, and then by driving the
uncoupled receptor to clathrin-coated pits [3,4]. β-arres-
tin-dependent internalization of 7TMRs involves the
direct interaction of the carboxy-terminal part of β-
arrestins with the β2-adaptin subunit of the adaptor pro-
tein (AP)-2 complex [5]. Mutation of two arginines in this
region abrogates both the β-arrestin/AP2 interaction and
the clustering of β2-adrenergic receptor into clathrin-
coated pits [6]. Furthermore, β-arrestins bind directly to
clathrin in vitro [7]. As endocytic adaptors, β-arrestins also
interact with the small GTPase ADP-ribosylation factor
(ARF)-6 and its exchange factor nucleotide-binding site
opener (ARNO), and with the N-ethylmaleimide-sensitive
fusion protein (NSF) [8]. In HEK 293 cells stimulated by
isoproterenol, overexpression of β-arrestin V53D, or of a
β-arrestin (319–418) peptide, both impaired in their
receptor-binding ability [9], not only reduces the β2-
adrenergic receptor internalization level, but also
decreases ERK activation [10]. Likewise, inhibition of β-
arrestin 1 or 2 expression by RNA interference levels off
the isoproterenol-induced ERK phosphorylation [11].
Besides, fission of the clathrin endocytic vesicle from the
plasma membrane is in part achieved by the GTPase
dynamin. Overexpression of a defective K44A dynamin
mutated in its catalytic domain [12] impairs both receptor
internalization as well as ERK stimulation transduced by
the  δ-opioid receptor [13]. In sharp contrast, some
7TMRs, such as the α2a adrenergic receptor [14], activate
ERK without being internalized, whereas some others,
such as the metabotropic glutamate mGlu1 receptor,
require β-arrestins to activate ERK, but not through their
endocytosis-promoting ability [15]. Therefore, whether
7TMR-mediated ERK activation will depend on β-arrestin-
promoted internalization or not seems to be a receptor-
related issue.
The follicle-stimulating hormone receptor (FSH-R) is a
7TMR whose main effector is adenylate cyclase [16]. Once
bound to its agonist, the FSH-R gets phosphorylated by G
protein-coupled receptor kinases (GRKs), recruits β-
arrestins [17] and undergoes internalization [18-21].
Overexpression of β-arrestin 1 or 2 or of the β-arrestin
(319–418) peptide respectively reduces or increases cAMP
in response to FSH, as measured by a luciferase gene
reporter assay [17,22]. The FSH-R is expressed by two cell
types of the gonad, namely Sertoli cells in the testis, and
granulosa cells in the ovarian follicle [23]. ERK MAP
kinases have been shown to be activated upon FSH stim-
ulation of primary cultures of both cell types [24-26], and
this signaling pathway mediates the mitogenic response
of Sertoli cells to the hormone [24]. Previously, overex-
pression of β-arrestin 1 or 2 [21] or of the β-arrestin (319–
418) peptide and of the dynamin K44A [20] mutant had
been shown to affect the FSH-R internalization. But to
date, nothing is known about the role of β-arrestin-
dependent internalization in ERK activation by the FSH-R.
Here, we addressed this question in HEK 293 cells tran-
siently expressing the FSH-R, by enhancing internaliza-
tion with overexpressed wild-type β-arrestins or by
interfering with receptor internalization with the β-arres-
tin (319–418) construct or by the dynamin K44A mutant.
Methods
Materials
Porcine FSH (apparent molecular weight = 33,500 g/mol)
was purified by Dr Jean Closset (Université de Liège, Bel-
gium) [27]. Amphotericin B, penicillin, streptomycin,
glutamin, phenylmethylsulfonyl (PMSF), Na3VO4, leu-
peptin, pepstatin and aprotinin were from Sigma Chemi-
cal Co (St. Louis, MO). Dulbecco's minimum essential
medium (DMEM), minimum essential medium (MEM)
with Earle's salt, foetal calf serum (FCS), non essential
amino acids, trypsin-EDTA were all from Gibco-BRL Life
Technologies (Gaithersburg, MD). The Transfast™ trans-
fection reagent was from Promega Corp., Madison, WI.
Plasmids
The pRK-FSHR/3 was a kind gift of Dr R. Sprengel (Heidel-
berg, Germany). The pCMV5-rat β-arrestin 1 and pCMV5-
rat β-arrestin 2 were gifts of Dr R.J. Lefkowitz (Durham,
NC). The pcDNA3-β-arrestin (319–418) was given by Dr
J.L. Benovic (Philadelphia, PA) and the pcDNA3-
dynamin-K44A plasmid was provided by Dr S.L. Schmid
(La Jolla, CA).
Cell culture and transfection
HEK 293 cells were grown in MEM supplemented with 20
µM glutamin, 100 µM non essential amino acids, 10%
heat-inactived FCS, 10 U/ml penicillin and 10 µg/ml
streptomycin.
HEK 293 cells were grown and transfected in 75 cm2
flasks. Cells were maintained at 37°C in a humidified
atmosphere of 5% CO2. Fifty to eighty % confluent cells
in FCS-free medium were incubated for 1 hour with Trans-
fast reagent (800 ng per cm2 culture) and plasmid DNAReproductive Biology and Endocrinology 2006, 4:33 http://www.rbej.com/content/4/1/33
Page 3 of 11
(page number not for citation purposes)
encoding the FSH-R (200 ng per cm2) and β-arrestin
(319–418) (600 ng per cm2) or wild-type β-arrestins (200
ng per cm2) or dynamin K44A (600 ng per cm2), unless
otherwise stated. Empty plasmid was added in every cul-
ture wells to equalize transfected plasmid concentrations.
Twenty-four hours after transfection, cells were treated for
90 sec with 3 ml 0.25% trypsin and 1 mM EDTA, centri-
fuged 10 min at 100 g and seeded in 9.6 cm2 culture plates
with a dilution factor of 0.4. Seventy hours after transfec-
tion, cells were FCS-starved for 2 hours in 1 ml, and then
stimulated with 1 to 10 nM pFSH. Media were collected
and cells were scrapped. For further Western blot analysis,
HEK 293 cells were scrapped directly in Laemmli sample
buffer (Tris HCl 0. 25 M pH 6.8, 5% SDS, 50% glycerol,
50 mM β-mercaptoethanol, 0.01% bromophenol blue).
Western blots
HEK 293 cell lysates were preincubated for 30 min at
37°C before gel loading. Samples were resolved by SDS-
PAGE, electrophoretically transferred to polyvinylidene
difluoride (PVDF) membranes (NEN Life Science Prod-
ucts, Boston, MA) and hybridized with the antibodies
mentionned in the following. Anti-p44ERK1/p42ERK2 rabbit
polyclonal antibody (Cell Signaling Technology Inc.) was
used at 1:1,000 dilution. The anti-ERK rabbit polyclonal
antibody purchased from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA), was used at 1:10,000 dilution. The anti-
arrestin A1CT polyclonal antibody kindly provided by R.J.
Lefkowitz (Durham, NC), was used at a 1:10,000 dilution.
It recognizes the C-terminus of β-arrestins, and therefore
recognizes endogenous, overexpressed wild-type as well
as overexpressed (319–418) β-arrestins. Primary antibod-
ies were incubated with membranes in TBS (20 mM Tris,
150 mM NaCl) 0.1% Tween-20 supplemented with 5%
unfat milk for 18 hours at 4°C under constant agitation.
Horseradish peroxydase-coupled anti-rabbit antibody
(Bio-Rad Laboratories Inc., Marnes-la-Coquette, France)
was used at 1:5,000 dilution, to detect antigen-antibody
interactions by enhanced chemioluminescence (NEN Life
Science Products). To monitor protein loading, a first
Western blot was hybridized with the anti-P-ERK anti-
body, the membrane was stripped 30 min at 50°C in 100
mM β-mercaptoethanol, 2% SDS, and rinsed twice for 10
min at room temperature in 150 mM NaCl, 0.05% Triton
X100. Then, the membrane was reprobed with anti-ERK
antibody. When β-arrestins were also probed with the
A1CT antibody, a second SDS-PAGE was achieved with
equal quantities of proteins as in the first gel, and Western
blot was carried on. The ratio of phosphorylated ERK2 to
total ERK2 was quantified using the ImageMaster 1D Elite
version 4 Software (Amersham Biosciences, Arlington
Heights, IL) and the results were expressed as phospho-
ERK/ERK.
125Iodo-FSH labelling (iodination)
Five µl (70 pmol) pFSH were incubated for 20 minutes
with 25 µg of lyophylized iodo-gen and 2 µl containing
100 µCi 125Iodine with specific activity of 2,670 Ci/mmol.
Separation of 125Iodo-FSH was performed on a Sephadex
G50 column and the iodination efficiency was around
65%.
Cell surface and internalized 125Iodo-FSH binding
Internalization assay procedures were described previ-
ously [18]. Briefly, cells plated in 9.6 cm2 wells were
placed in 950 µl of Waymouth's MB752/1 containing 1
mg/ml bovine serum albumin (BSA) and 20 mM Hepes
pH 7.4 for 2 h at 37°C. Each well received around 500,
000 cpm 125I-FSH (160 pM final concentration) alone or
added with unlabelled pFSH (160 nM final concentra-
tion) in 50 µl. Total and non-specific binding were
assayed in triplicates. At the indicated timepoints, cells
were placed on ice and washed three times with 1 ml of
cold Hanks' balanced salt solution containing 1 mg/ml
BSA. The surface-bound hormone was then released by
incubating cells in 1 ml of cold 50 mM glycine, 150 mM
NaCl, pH 3.0 for 4 min. The buffer was withdrawn and
counted, the cells were collected with 300 µl of 0.5 N
NaOH and were also counted.
Expression of results and statistical analysis
Results were expressed as mean + S.E.M., unless otherwise
indicated. Comparison of the results was based on vari-
ance analysis. A probability (P) value below 5% was con-
sidered as significant.
Results
FSH stimulates ERK phosphorylation in HEK 293 cells
In HEK 293 cells transiently expressing the rat FSH-R, FSH
stimulated ERK phosphorylation in a dose-dependent
manner (Figure 1A, 1B). Based on these data, the optimal
dose of FSH to be used in the following was determined
as 3 nM FSH, which is close to the KD of FSH in testicular
fractions [23]. In a time-course experiment, FSH stimu-
lated ERK phosphorylation as soon as 2 minutes of expo-
sure. ERK phosphorylation peaked around 6 min, then
declined slowly, since 44% of the maximum phosphor-
ylation was still observed by 15 min of FSH stimulation
(Figure 1C, 1D). By 60 min, there was still more than
twice as much the basal level of ERK phosphorylation
(data not shown). No ERK phosphorylation was detected
in cells exposed to a vehicle or in control cells transfected
with an empty plasmid (Figure 1D).
Characterization of the FSH-R internalization
In order to evaluate whether blocking internalization
impacts on FSH-stimulated ERK phosphorylation, it was
first necessary to characterize the parameters of FSH-R
internalization in our experimental conditions. For thatReproductive Biology and Endocrinology 2006, 4:33 http://www.rbej.com/content/4/1/33
Page 4 of 11
(page number not for citation purposes)
FSH stimulates ERK phosphorylation in HEK 293 cells expressing the rat R-FSH Figure 1
FSH stimulates ERK phosphorylation in HEK 293 cells expressing the rat R-FSH. A: Quantification of the P-ERK/ERK ratio (n = 
3 independent experiments) in response to increasing doses of FSH for 6 min. B: Representative autoradiograph of dose-
dependent FSH-induced ERK phosphorylation. C: Quantification of P-ERK (n ≥ 3 experiments) in response to FSH stimulation 
from 2 to 15 min. D. Representative autoradiograph showing the time-course of FSH-induced ERK phosphorylation in cells 
expressing the FSH-R or transfected with an empty plasmid, as indicated. In 1A and 1C, results are expressed as means + 
S.E.M. of fold stimulation over basal level. Shared superscripts indicate no significant difference, while different superscripts 
indicate significant differences at the P > 0.05 level.
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purpose, cells were placed in the same experimental con-
ditions as those used to visualize ERK phosphorylation,
except that pFSH was replaced by I125-labeled pFSH. The
kinetics of FSH binding we obtained (Figure 2A) were in
agreement with reference data obtained in testicular frac-
tions [28] and in HEK 293 cells exogenously expressing
the FSH-R [28]. The ratio of internalized 125I-FSH binding
versus total binding increased rapidly up to 10 min, then
more slowly over time (Figure 2B), so that internalization
of the FSH-R in response to FSH did not exceed 50% over
time.
The dominant negative β-arrestin (319–418) construct or 
the dynamin K44A mutant reduces the ratio of internalized 
125Iodo-FSH binding without altering FSH-induced ERK 
phosphorylation
We next investigated whether FSH-R internalization was
required to generate the FSH-induced ERK response.
Kinetics of FSH-R internalization Figure 2
Kinetics of FSH-R internalization. Binding experiments showing internalized and cell-surface FSH-R (A) or showing the internal-
ization ratio (B) in the same culture wells, for times ranging from 4 to 60 min of stimulation with 125I-pFSH. Results are 
expressed as the ratio of internalized 125I-FSH binding versus total (membrane + internalized) binding. Data show the mean + 
S.E.M. of 5 independent experiments.
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Transfection of 600 ng of β-arrestin (319–418) or of the
GTPase-deficient dynamin K44A mutant reduced the ratio
of internalized FSH-R after 8 min of 125Iodo-FSH expo-
sure, a timepoint when ERK phosphorylation peaked (Fig-
ure 3A). Even in the presence of 2 µg of β-arrestin (319–
418) or dynamin K44A, it was not possible to decrease
further the internalization level, suggesting that at maxi-
mum 40% inhibition of internalization could be reached
in these conditions. In time-course experiments with 125I-
FSH exposure from 4 to 60 min, the level of inhibition of
FSH-R internalization by β-arrestin (319–418) (Figure
3B) or by dynamin K44A (Figure 3C) was constant over
time. Transfection of β-arrestin (319–418), visualized by
immunoreaction with the A1CT anti-arrestin antibody,
did not alter ERK phosphorylation levels after 4, 8 or 12
minutes of FSH exposure (Figure 4A). Likewise, transfec-
tion of the K44A dynamin mutant left the FSH-stimulated
ERK phosphorylation level unchanged. Figure 4B shows
that there is no difference in the quantification of phos-
phorylated versus total ERK between cells transfected with
β-arrestin (319–418) or dynamin K44A and control cells.
Therefore, inhibiting β-arrestin- or dynamin-mediated
FSH-R internalization did not alter FSH-induced ERK
phosphorylation.
Overexpression of wild-type β-arrestin 1 or 2 increases 
internalized 125Iodo-FSH binding without affecting FSH-
induced ERK phosphorylation
Symetrically, overexpression of wild-type β-arrestin 1 or β-
arrestin 2 enhanced the FSH-R internalization (Figure
5A). In time-course experiments with 125I-FSH exposure
from 4 to 60 min, the increase in FSH-R internalization by
β-arrestin 1 or 2 was constant over time (Figure 5B). β-
arrestin 2 appeared slightly more effective than β-arrestin
1 in enabling internalization of the FSH-R. However,
expression of both arrestins had no additive effect. β-
arrestin overexpression led to more than 70% of the con-
trol level of FSH-R internalization. The actual level of
overexpressed  β-arrestins was individually immunode-
tected with the A1CT antibody (Figure 5C). The increase
in FSH-R internalization obtained after transfection of 50
or 200 ng of β-arrestin 1 or of β-arrestin 2 did not alter
FSH-induced ERK phosphorylation. Both quantities of β-
arrestins led to a plateau in the FSH-R internalization level
(Figure 5C, lower part). Figure 5D shows that there is no
difference in the quantification of phosphorylated versus
total ERK between cells overexpressing β-arrestin 1 or β-
arrestin 2 and control cells.
In conclusion, these data show that an increase in β-arres-
tin-mediated FSH-R internalization level had no effect on
the ERK response.
Discussion
Our results clearly show that interfering with the FSH-R
internalization by β-arrestin (319–418) or by dynamin
K44A did not affect the ability of FSH to enhance ERK
phosphorylation. Consistently, overexpression of β-
arrestins 1 and 2 increased the percentage of FSH-R inter-
nalization but did not alter the ability of FSH to increase
ERK phosphorylation. Therefore, we conclude that β-
arrestin-dependent internalization is not required for
FSH-induced ERK phosphorylation.
Our data are concordant with previous reports showing
that expression of β-arrestin (319–418) or of dynamin
K44A impaired the FSH-R internalization rate [18,20,29].
Here, we extended these works, but even by increasing
doses of interfering mutants, and in kinetics experiments,
the FSH-R internalization could not be inhibited by more
than 50%, in agreement with these reports. To validate
our experimental framework, we also confirmed that
overexpression of β-arrestin 1 [21] and β-arrestin 2
[20,21] enhanced the FSH-R internalization rate. By a sim-
ilar approach, it is possible to enhance ERK phosphoryla-
tion in response to angiotensin II [30].
Interestingly, our results suggest a difference in the effi-
ciency of β-arrestins 1 and 2 to promote FSH-R internali-
zation, in contrast to previously reported data [21]. Non-
redundant functions for β-arrestins have previously been
documented for other receptors. For example, whereas
internalization of the agonist-induced β2-adrenergic
receptor is insensitive to β-arrestin-1 depletion by RNA
interference,  β-arrestin-2 depletion has a dramatically
inhibitory effect [31]. In addition, a reduction in β-arres-
tin 2, but not in β-arrestin 1 expression by siRNA, inhibits
the ability of Angiotensin II to increase ERK phosphoryla-
tion, in HEK 293 cells transfected with the Angiotensin II
type 1A receptor [32]. Likewise, vasopressin type 2 recep-
tor-mediated ERK phosphorylation is sensitive to β-arres-
tin 2, but not to β-arrestin 1 suppression [33]. In sharp
contrast, β-arrestin 1 and 2 have similar effects on parath-
yroid hormone receptor-mediated [34] or on β2-adrener-
gic receptor-dependent ERK activation [11]. Therefore,
whether or not each β-arrestin has a specific action seems
to vary according to the receptor.
Albeit the FSH-R internalization level does not seem cru-
cial for FSH-induced ERK phosphorylation, we cannot
exclude an internalization-independent role of β-arrestins
to achieve this response. Importantly, in the last years, β-
arrestin function has extended far beyond receptor desen-
sitization and endocytosis, by virtue of their ability to scaf-
fold MAP kinase signaling modules, as well as elements of
the inositide-dependent pathways [35,36]. It has been
extensively reported that β-arrestins can scaffold an entire
MAP kinase cascade, including a MAPKKK such as Raf-1 orReproductive Biology and Endocrinology 2006, 4:33 http://www.rbej.com/content/4/1/33
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Inhibitory effect of the dynamin K44A and β-arrestin (319–418) contructs on the FSH-R internalization Figure 3
Inhibitory effect of the dynamin K44A and β-arrestin (319–418) contructs on the FSH-R internalization. A: FSH-R internaliza-
tion in HEK 293 cells after 8 minutes 125I-FSH stimulation. Cells were transfected in triplicates with a plasmid encoding the 
FSH-R and with 600 ng or 2 µg of empty plasmid or plasmid expressing dynamin K44A or β-arrestin (319–418). B: Kinetics of 
FSH-R internalization in the presence (triangles) or absence (diamonds) of overexpressed (319–418) construct. C: Kinetics of 
FSH-R internalization in the presence (triangles) or absence (diamonds) of overexpressed K44A dynamin.
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ASK1, a MAPKK such as MKK4/7 or MEK1/2 and a MAPK
such as ERK [37], JNK [38] and p38 [39].
The mechanism of ERK activation is a crucial determinant
of ERK-induced physiological response. A two-step proc-
ess has recently been proposed to lead to ERK activation
in response to 7TMR agonists: an early G protein-depend-
ent mechanism followed by a β-arrestin-mediated mecha-
nism leading to ERK phosphorylation by 10 minutes of
Angiotensin II exposure [40]. Whereas the early and tran-
sient G-protein-activated ERK translocates to the nucleus
to phosphorylate its target transcriptional regulators, the
late and sustained β-arrestin-activated ERK accumulates in
a pool of cytoplasmic vesicles [41] to constrain ERK activ-
ity to phosphorylation of its extra-nuclear targets. Like-
wise, retention of the proteinase-activated receptor-2 in
the cytoplasm by a β-arrestin-containing signaling com-
plex retains ERK in the cytoplasm, thus preventing a
Inhibition of dynamin- or β-arrestin-mediated FSH-R internalization does not impair FSH-induced ERK phosphorylation Figure 4
Inhibition of dynamin- or β-arrestin-mediated FSH-R internalization does not impair FSH-induced ERK phosphorylation. A: 
Immunodetection of P-ERK, of endogenous β-arrestins and of β-arrestin (319–418) as indicated, following 4, 8 and 12 min of 
FSH stimulation. n.s. = non specific. MWM = molecular weight marker (kDa). B: Quantification of P-ERK in response to 8 min 
of FSH stimulation (n = 3 independent experiments).
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Increasing β-arrestin-mediated internalization of the FSH-R does not change ERK phosphorylation Figure 5
Increasing β-arrestin-mediated internalization of the FSH-R does not change ERK phosphorylation. A. FSH-R internalization 
after 8 minutes of 125I-FSH exposure. Cells were transfected in sexplicates with the FSH-R and with 2 µg β-arrestin 1 or β-
arrestin 2 or of empty plasmid. B: Kinetics of FSH-R internalization in the absence (diamonds) or presence of overexpressed β-
arrestin 1 (squares) or β-arrestin 2 (triangles). C: immunodetection of P-ERK and of endogenous β-arrestin 1 or 2 as indicated, 
following 6 min of FSH exposure. The percentage +/- S.E.M. of FSH-R internalization in the presence of 50 or 200 ng of β-
arrestins is indicated below the autoradiograms. D: Quantification of P-ERK (n = 4 independent experiments) in response to 6 
min of FSH stimulation.
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mitogenic response [37]. Therefore, fine-tuning the mech-
anism of ERK activation by G protein and/or by β-
arrestins is a major determinant of an agonist-induced
ultimate cellular response. Our own studies on the FSH-R
using β-arrestin siRNA indicate that prolonged ERK phos-
phorylation upon FSH stimulation requires β-arrestins
(See additional file 1: Kara et al., submitted). Therefore,
since β-arrestins are required for FSH-induced ERK phos-
phorylation, and since ERK phosphorylation occurs even
though internalization is markedly reduced, our results
raise the appealing possibility that FSH would activate
ERK at the plasma membrane. β-arrestins would assemble
their MAPK signaling modules at the plasma membrane,
or, alternatively, they would recruit a preformed complex,
similarly to the JNK3 signaling module [38]. This point
requires further investigations.
In granulosa cells, B-Raf, Rap-1 and MEK are constitu-
tively active and lead to ERK phosphorylation. However,
ERK is constitutively dephosphorylated by a phosphatase
which is blocked by FSH, in a G-protein/PKA-dependent
manner [26]. This leads to ERK translocation to the
nucleus, as further substantiated by our own data
obtained in Sertoli cells [24]. These results do not exclude
that β-arrestins could intervene later in the kinetics of acti-
vation, to sequester activated ERK in the cytosol, as previ-
ously reported for other GPCRs, such as the AT1a-R [30]
or the PAR-2 [37].
In conclusion, our study provide clear evidence that, in
contrast to many 7TMRs, β-arrestin-mediated FSH-R inter-
nalization is not required for ERK activation by FSH.
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